Primary care providers and pediatricians play an invaluable role in the diagnosis of diabetes mellitus and timely interventions. “Diagnosing diabetes mellitus often starts with pediatricians or other primary care providers when parents bring in their child for unexplained weight loss, frequent urination and excessive fluid consumption,” said Brad Thrasher, D.O., MBA, pediatric endocrinologist with Wendy…
Mary E. Dedman, M.D. Pediatrics Thomas E. McCormick, M.D. Pediatrics Leigh A. Nieto, M.D. Pediatrics Lorraine A. Rust-Killeen, M.D. Pediatrics Kerby D. Albert, APRN Neonatology Amy M. Barry, APRN Neonatology Emily A. Hickerson, APRN Neonatology
Insulin administration has advanced well beyond the “old school” delivery with a vial and syringe. Patients with Type 1 and Type 2 diabetes mellitus cared for at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine, are often prescribed a prefilled insulin pen with a choice of dosing…
Jennifer O. Hockenbury, M.D. Pediatric Emergency Medicine Angela M. Jeffries, M.D. Pediatric Gastroenterology Benjamin H. Lyvers, M.D. Pediatric Emergency Medicine Ivory J. Shelton, M.D. Pediatric Emergency Medicine Leena Mohapatra, Ph.D. Pediatric Neurosurgery Jennifer L. Dumey, APRN Child Abuse Pediatrics Missy S Hawes, APRN Pediatrics Julianne Higdon, APRN Pediatric Cardiology Karen L. Jennings, APRN…
Rachel L. Evans, M.D. Pediatric Neurology Stephanie M. Green, D.O. Pediatric Physical Medicine and Rehabilitation Kelly A. Jenkins, M.D. Pediatric Orthopedic Surgery Michael S. Orangias, M.D. Pediatric Pulmonology, Pediatric Sleep Medicine Huma N. Rasheed, M.D. Pediatric Cardiology Zachery T. Sensing, M.D. Hospital Medicine Jennifer Smith, M.D. Pediatric Hospital Medicine Frederick J. Stocker…
Christie Buonpane, M.D. Pediatric General Surgery Claire E. Milligan, Ph.D. Pediatric Psychology Kathryn R. Gallegos, APRN Pediatric Neurology Austin Peters, APRN Pediatrics Corinne M. Streble, APRN Pediatric Cardiology
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and children ages 8 and older with Stage 2 Type 1 diabetes. “Delaying the onset of Stage 3 not only postpones…
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton Children’s is one of 40 sites nationally participating in the Phase 3 trial. Afrezza is an ultra-fast-acting inhaled mealtime insulin,…
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric neuro-oncologist at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, looks at whether DFMO offers a new…
Surgeons face two choices for infants with critical left heart obstruction who have had prior hybrid palliation: a Norwood operation or a comprehensive stage II (COMPSII). The critical left heart obstruction cohort of the multi-institutional Congenital Heart Surgeons’ Society looked at patient characteristics and outcomes for these two pathways. The study, “Norwood Operation Versus Comprehensive…
Patients often suspect a thyroid condition is responsible for their weight gain or their weight loss struggles. Much of the stimulus for this belief is based on the internet, according to Lisal J. Folsom, M.D., M.S., a pediatric and adult endocrinologist with Norton Community Medical Associates and Norton Children’s Endocrinology, affiliated with the UofL School…